AG
Artal Group Portfolio holdings
AUM
$930M
This Quarter Return
+21.99%
1 Year Return
-3.57%
3 Year Return
+157.23%
5 Year Return
+160.22%
10 Year Return
+1,359.85%
AUM
$6.8B
AUM Growth
+$6.8B
(+27%)
Cap. Flow
+$226M
Cap. Flow
% of AUM
3.33%
Top 10 Holdings %
Top 10 Hldgs %
92.21%
Holding
134
New
22
Increased
25
Reduced
13
Closed
23
Top Buys
| 1 |
ONC
BeOne Medicines Ltd. American Depositary Shares
ONC
|
$50.4M |
| 2 |
BPMC
Blueprint Medicines
BPMC
|
$32.1M |
| 3 |
Nektar Therapeutics
NKTR
|
$31.9M |
| 4 |
TSRO
TESARO, Inc.
TSRO
|
$28.6M |
| 5 |
Amicus Therapeutics
FOLD
|
$22.6M |
Top Sells
| 1 |
Neurocrine Biosciences
NBIX
|
$19.4M |
| 2 |
Incyte
INCY
|
$16.7M |
| 3 |
GBT
Global Blood Therapeutics, Inc.
GBT
|
$7.25M |
| 4 |
CLVS
Clovis Oncology, Inc.
CLVS
|
$6.8M |
| 5 |
ALDR
Alder Biopharmaceuticals, Inc.
ALDR
|
$5.73M |
Sector Composition
| 1 | Consumer Staples | 51.19% |
| 2 | Consumer Discretionary | 27.58% |
| 3 | Healthcare | 20.59% |
| 4 | Communication Services | 0.17% |
| 5 | Materials | 0.06% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
NovaGold Resources
NG
$2.73B
| $4.33M | 0.05% |
+1,000,000
| New | +$4.33M |
|
52
Adicet Bio
ACET
$60.8M
| $4.31M | 0.05% |
+64,286
| New | +$4.31M |
|
|
DRNA
53
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
| $4.06M | 0.05% |
+425,000
| New | +$4.06M |
|
54
Synlogic
SYBX
$17.4M
| $3.75M | 0.05% |
26,667
-10,000
| -27% | -$1.41M |
|
55
InflaRx
IFRX
$117M
| $3.61M | 0.05% |
+125,000
| New | +$3.61M |
|
56
TG Therapeutics
TGTX
$5.03B
| $3.55M | 0.04% |
250,000
-150,000
| -38% | -$2.13M |
|
57
Viridian Therapeutics
VRDN
$1.59B
| $3.51M | 0.04% |
33,333
+26,666
| +400% | +$2.8M |
|
58
Ironwood Pharmaceuticals
IRWD
$201M
| $3.35M | 0.04% |
258,954
-358,200
| -58% | -$4.63M |
|
|
PTLA
59
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
| $3.27M | 0.04% |
100,000
-50,000
| -33% | -$1.63M |
|
|
CMTA
60
DELISTED
Clementia Pharmaceuticals Inc.
CMTA
| $3.03M | 0.04% |
+200,000
| New | +$3.03M |
|
61
Sangamo Therapeutics
SGMO
$161M
| $2.85M | 0.04% |
+150,000
| New | +$2.85M |
|
|
ACHN
62
DELISTED
Achillion Pharmaceuticals, Inc.
ACHN
| $2.78M | 0.03% |
750,000
| – | – |
|
|
CMRX
63
DELISTED
Chimerix, Inc.
CMRX
| $2.6M | 0.03% |
500,000
| – | – |
|
64
Adverum Biotechnologies
ADVM
$68.2M
| $2.32M | 0.03% |
+40,000
| New | +$2.32M |
|
65
Syndax Pharmaceuticals
SNDX
$1.39B
| $2.14M | 0.03% |
150,000
| – | – |
|
|
MRNS
66
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
| $1.91M | 0.02% |
125,000
+75,000
| +150% | +$1.15M |
|
67
Intellia Therapeutics
NTLA
$1.26B
| $1.9M | 0.02% |
90,000
-160,000
| -64% | -$3.37M |
|
68
Kura Oncology
KURA
$732M
| $1.88M | 0.02% |
100,000
| – | – |
|
69
Minerva Neurosciences
NERV
$16.8M
| $1.88M | 0.02% |
37,500
+6,087
| +19% | +$304K |
|
70
Q32 Bio
QTTB
$20.9M
| $1.87M | 0.02% |
+5,556
| New | +$1.87M |
|
71
Krystal Biotech
KRYS
$4.35B
| $1.51M | 0.02% |
150,000
| – | – |
|
|
ATYR
72
aTyr Pharma
ATYR
$560M
| $1.33M | 0.02% |
35,714
| – | – |
|
73
Cartesian Therapeutics
RNAC
$267M
| $1.27M | 0.02% |
+4,167
| New | +$1.27M |
|
74
Forte Biosciences
FBRX
$138M
| $1.19M | 0.01% |
267
| – | – |
|
75
CRISPR Therapeutics
CRSP
$4.82B
| $1.14M | 0.01% |
25,000
-25,000
| -50% | -$1.14M |
|